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ABSTRACT
Single-cell profiling techniques create opportunities to delineate cell
fate progression in mammalian development. Recent studies have
provided transcriptome data from human pre-implantation embryos,
in total comprising nearly 2000 individual cells. Interpretation of these
data is confounded by biological factors, such as variable embryo
staging and cell-type ambiguity, as well as technical challenges in the
collective analysis of datasets produced with different sample
preparation and sequencing protocols. Here, we address these
issues to assemble a complete gene expression time course
spanning human pre-implantation embryogenesis. We identify key
transcriptional features over developmental time and elucidate
lineage-specific regulatory networks. We resolve post-hoc cell-type
assignment in the blastocyst, and define robust transcriptional
prototypes that capture epiblast and primitive endoderm lineages.
Examination of human pluripotent stem cell transcriptomes in this
framework identifies culture conditions that sustain a naïve state
pertaining to the inner cell mass. Our approach thus clarifies
understanding both of lineage segregation in the early human
embryo and of in vitro stem cell identity, and provides an analytical
resource for comparative molecular embryology.
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INTRODUCTION
Three distinct cell lineages are established in the mammalian
blastocyst: trophectoderm (TE), which supports uterine
implantation and development of the placental epithelia; extra-
embryonic primitive endoderm (PrE), from which the primary yolk
sac is formed; and pluripotent epiblast (EPI), which gives rise to the
embryo proper. In the human embryo, the first lineage segregation
becomes apparent at embryonic day (E) 4-5, when the compacted
morula undergoes cavitation to initiate blastocyst formation. Inner
cells are directed towards the inner cell mass (ICM), whereas outer
cells acquire TE fate.
Unlike in mouse, the pluripotency factor POU5F1 (also known as
OCT4) is widely expressed in both early ICM and TE in the early
human blastocyst (Niakan and Eggan, 2013). By E6 in human,
POU5F1 is downregulated in TE but remains expressed in all cells
of the ICM (Chen et al., 2009; Deglincerti et al., 2016; Niakan and
Eggan, 2013). ICM cells with high POU5F1 levels often co-express
NANOG (Roode et al., 2012; Deglincerti et al., 2016), suggesting a
prospective EPI fate. Lower POU5F1 levels correlate with PrE-
specific SOX17 expression (Roode et al., 2012; Niakan and Eggan,
2013).
Initial co-expression of NANOG and GATA6 in a subset of early
ICM has also been observed in human (Roode et al., 2012) and non-
human primates (Boroviak et al., 2015). In human blastocysts
exceeding 200 cells, EPI and PrE marker profiles appear to be
mutually exclusive (Niakan and Eggan, 2013): EPI cells are
associated with NANOG and high POU5F1 expression, whereas
PrE cells are characterised by GATA6, SOX17, GATA4 and
diminishing levels of POU5F1 (Roode et al., 2012; Deglincerti
et al., 2016). These features indicate EPI and PrE segregation in the
peri-implantation blastocyst between E6 and E7. Selective in situ
analyses have contributed seminal knowledge of key regulatory
events that underlie early lineage progression in primate
development. However, detailed characterisation of human
embryogenesis on a genome-wide molecular level has been lacking.
Various high-throughput profiling methods have recently been
applied to gene expression and DNA methylation analysis of
embryos from several mammalian species, including mouse (Guo
et al., 2010, 2014; Ohnishi et al., 2014; Boroviak et al., 2015),
human (Xue et al., 2013; Yan et al., 2013; Blakeley et al., 2015;
Petropoulos et al., 2016) and non-human primates (Boroviak et al.,
2015; Nakamura et al., 2016). These studies have yielded broad
overviews of epigenetic status and transcriptional activity in early
embryonic development.
To date, three reports provide single-cell RNA-sequencing
(RNA-seq) data from human embryos to the blastocyst stage,
entailing a total of 1683 individual transcriptomes [Yan et al., 2013
(n=124); Blakeley et al., 2015 (n=30); Petropoulos et al., 2016
(n=1529)]. The studies differ in scope of developmental timespan,
sample collection and processing, sequencing protocol and cell-
type classification. Such differences present substantial analysis
challenges that impair direct comparison of embryonic lineages
between datasets (Vallot et al., 2017). The accurate and consistent
distinction of EPI and PrE cells has proven particularly difficult and
consequently impedes the analyses of fate specification events.
Here, we undertake a comprehensive analysis of human embryo
single-cell transcriptome datasets, characterising the features of
each and resolving ambiguities in cell-type assignments. We build a
unified transcription map comprising representative samples of
defined embryonic lineages. The associated gene expression
signatures recapitulate known lineage marker protein localisationReceived 17 August 2017; Accepted 4 January 2018
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in embryos assayed by immunofluorescence, and enable the
discovery of specific transcriptional events and regulatory
networks over developmental time. This study provides detailed
insight into the emergence of pluripotency in the human embryo
and an analytical framework in which to assess the developmental
state of self-renewing pluripotent cell lines cultured ex vivo.
RESULTS
TE over-representation in single-cell embryo data
We embarked on a systematic analysis of single-cell transcriptome
data from three human embryo profiling studies that extend to late
blastocyst (Yan et al., 2013; Blakeley et al., 2015; Petropoulos et al.,
2016). When examining the most extensive dataset produced to date
(Petropoulos et al., 2016), global analysis of EPI and PrE cells as
classified in that study showed substantial overlap between the two
populations (Fig. 1A, Fig. S1A). Alternative dimensionality
reduction algorithms, such as t-distributed stochastic neighbour
embedding (t-SNE) (Fig. S1B) and diffusion map visualisation
methods (Fig. S1C), generated consistent sample clusters.
Moreover, lack of separation between EPI and PrE cells could not
be attributed to potential differences in samples collected at E6 and
E7 (Fig. S1D). A degree of transcriptional identity may be expected
as it has been noted that EPI and PrE share broadly similar
expression profiles at early blastocyst stages in the mouse embryo,
and are most effectively distinguished by a subset of marker genes
(Boroviak et al., 2015). However, significant contribution from
genes enriched in TE was observed in the first dimension of
principal component analysis (PCA) (Fig. 1B). Thus, when the
entire dataset is considered as an ensemble, the presence of TE cells
impedes accurate resolution of EPI and PrE and subsequent
characterisation of those lineages.
A subset of samples from Petropoulos et al. was obtained from
embryos treated by immunosurgery, which canonically entails
ablation of the TE by complement-mediated cell lysis and
mechanical isolation of intact ICM (Solter and Knowles, 1975).
To determine the properties of EPI and PrE lineages in a dataset
presumed to be devoid of TE cells, we examined those samples
captured via immunosurgery from late blastocysts at E6 and E7. At
this stage, EPI and PrE are largely discerned by marker analysis
(Roode et al., 2012; Niakan and Eggan, 2013). However, PCA
based on the most variable genes did not yield distinct EPI and PrE
populations (Fig. 1C). Plotting the ratio of NANOG (EPI) versus
PDGFRA (PrE) expression revealed an EPI population co-mingled
with a minority of PrE cells, but the largest proportion displayed
intermediate levels of NANOG and PDGFRA (Fig. 1C). The
predominant genes contributing to the separation of samples were
TE associated, includingGATA2,GATA3,KRT8,DAB2 and TEAD3
(Fig. S1E). Indeed, many of the cells concerned were classified as
TE in the primary report (Petropoulos et al., 2016). Samples were
derived from four E6 and six E7 embryos (Fig. 1D) and more than
half were annotated to belong to the TE lineage (Fig. 1E). This is
highly unexpected and suggests incomplete immunolysis and ICM
recovery in the original study.
Lineage markers defining human EPI, PrE and TE
We sought to compile a robust dataset of representative EPI and
PrE transcriptomes from available single-cell profiling data.
Ideally, this dataset should contain samples from each of the
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Fig. 1. Embryo lineage classification.
(A) PCA of E6 and E7 samples based on
the most variable genes (n=1294, log2
FPKM>2, log CV2>0.5), coloured
according to cell type classification by
Petropoulos et al. (2016). (B) Genes
contributing to the first and second
principal components. (C) PCA of E6 and
E7 immunosurgery samples from
Petropoulos et al. based on variable genes
(n=1131, log2 FPKM>2, log CV2>0.5).
Colours are scaled to the ratio of NANOG
(EPI) to PDGRA (PrE) expression.
(D) Lineage assignments of E6 and E7
immunosurgery samples according to
Petropoulos et al. (E) Relative percentages
of EPI, PrE and TE cells from embryos
processed by immunosurgery as reported
by Petropoulos et al.
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three published studies (Yan et al., 2013; Blakeley et al., 2015;
Petropoulos et al., 2016) and recapitulate known lineage marker
localisation (Kuijk et al., 2012; Roode et al., 2012; Niakan and
Eggan, 2013; Blakeley et al., 2015; Deglincerti et al., 2016; Guo
et al., 2016). We assembled a set of 12 high-confidence marker
genes described in the literature, four associated with each of the
three blastocyst lineages (Fig. 2A). We evaluated the
discriminatory power of these genes on cells profiled in the Yan
and Blakeley studies (Fig. 2B,C). We found that clear separation
between EPI, PrE and TE could be attained for nearly all
samples. This result indicates that post-hoc identification of
early human embryo cells based on this minimal set of lineage
markers is compatible with the cell-type classification
proposed by Blakeley et al. (Fig. S2A, Table S1), and further
confirms those assignments as consistent with published
immunofluorescence data.
Upon inclusion of E6-E7 EPI and PrE samples as annotated in the
Petropoulos study, we observed substantial overlap between EPI,
PrE and TE cells from all three studies, with limited dispersion of
Petropoulos samples that precluded resolution of distinct lineages
(Fig. S2B). PCA of a combined dataset comprising Blakeley and
Yan cells with the Petropoulos immunosurgery subset revealed
substantial apparent technical bias between the Petropoulos study
and others, largely captured by PC1 (Fig. S2C,D). To mitigate these
differences and allow meaningful comparisons between studies, we
identified the most variable genes in each dataset (Fig. S2E).
Intersecting these yielded 188 genes common to all (Fig. S2F). PCA
confined to this gene set showed a substantial reduction in technical
bias (Fig. 2D). This analysis further confirmed that the majority of
immunosurgery-derived samples in the Petropoulos study are likely
to originate from TE. PCA based on lineage markers produced
similar results (Fig. 2E).
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Fig. 2. Lineage segregation based on
marker genes. (A) Panel of 12 high-
confidence markers for EPI, PrE and TE.
Publications with immunofluorescence
data showing protein expression in the
human blastocyst are highlighted in blue.
A subset of TE cells express CDX2 in
human (Chen et al., 2009; Niakan and
Eggan, 2013). (B) PCA of embryo cells
profiled in the Yan and Blakeley
studies based on lineage markers.
(C) Hierarchical clustering of Yan and
Blakeley datasets. (D,E) PCA of EPI, PrE
and TE with E6 and E7 Petropoulos
immunosurgery samples (grey) based on
common variable genes (n=188, log2
FPKM>2, log CV2>0.5) (D) or based on
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Representative transcriptomes of mature EPI and PrE
lineages
To date, the Petropoulos study embodies the most extensive human
embryo single-cell transcriptome resource, comprising 858 late
blastocyst samples among 1529 total sequenced. To discriminate
presumptive EPI and PrE from TE cells in this dataset, we examined
POU5F1 expression at the late blastocyst stage. Immunofluorescence
assays have tracked POU5F1 expression from E3 (8-cell) to E7 (late
blastocyst) and revealed that localisation is nonspecific in all cells of
the compacted morula and spans most cells of the early blastocyst
(Fig. 3A; Niakan and Eggan, 2013). From the mid-blastocyst stage,
POU5F1 is gradually restricted to the ICM. Notably, POU5F1 is
expressed in the ICM throughout pre-implantation development
(Niakan and Eggan, 2013).
To determine whether similar dynamics were evident at the
transcript level, we examined POU5F1 expression across
developmental stages (Fig. 3B, Fig. S3A,B). POU5F1 mRNA
levels closely resembled the pattern of protein abundance observed
throughout the embryo as established by immunostaining. At mid-
to late-blastocyst stages (E6 and E7), POU5F1 downregulation was
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(A) Schematic of pre-implantation
development from the 8-cell
stage according to published
immunofluorescence assays (Niakan
and Eggan, 2013). Colours depict
POU5F1 localisation typical of each
stage. (B) PCA of Petropoulos samples
based on variable genes (log2 FPKM>2,
log CV2>0) according to embryonic day.
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expression. (C,D) Dendrograms of E6
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(E) PCA of Petropoulos samples based
on common variable genes (n=170, log2
FPKM>2, log CV2>0.5) with high and
medium POU5F1 levels as selected in
C and D, together with EPI and PrE cells
from Yan and Blakeley datasets.
(F) PCA based on marker genes as
described in E.
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seen in the majority of cells, apart from a small population
representing the late ICM (Fig. 3B, Fig. S3A,B). To extract this set,
we performed hierarchical clustering based on the third principal
component to distinguish cells expressing high levels of POU5F1
(POU5F1-high) from those expressing low levels (POU5F1-low)
(Fig. 3C,D). This facilitated isolation of clusters of E6 (Fig. 3C) and
E7 (Fig. 3D) cells displaying medium and high POU5F1
expression. PCA based on highly variable genes (Fig. 3E) and
lineage markers (Fig. 3F) revealed close correspondence of E6 and
E7 POU5F1-high cells to EPI and PrE samples from the Blakeley
and Yan datasets. EPI and PrE cells segregated along PC1,
suggesting that separation of these groups is largely attributed to
biological differences between the two lineages. Exclusive selection
of POU5F1-high clusters (Fig. S3C,D) produced similar results,
although we noted a slight under-representation of PrE cells
(Fig. S3E,F). This is consistent with expression patterns observed in
the late human blastocyst, in which POU5F1 appears to be higher in
EPI than in PrE (Roode et al., 2012). We conclude that POU5F1
mRNA levels recapitulate previously observed protein localisation.
Thus, identification of POU5F1-high and POU5F1-medium sample
groups facilitates a posteriori separation of ICM from TE cells.
Hierarchical clustering of POU5F1-high and POU5F1-medium
cells at E6 and E7, together with EPI and PrE samples from the Yan
and Blakeley datasets, produced three distinct populations
(Fig. 4A). NANOG:PDGFRA expression ratios in these cells are
indicative of EPI, PrE and an intermediate group. We derived
transcriptomes representing mature EPI and PrE lineages as well as
intermediate cells from the associated clusters (Fig. 4A), using data
from all studies considered. EPI and PrE samples formed discrete
groups by genome-wide expression (Fig. S4A) and marker-based
PCA (Fig. S4B). According to this classification, all EPI and PrE
cells exhibited robust expression of high-confidence lineage
markers, indicating mature EPI and PrE identity (Fig. 4B).
Intermediates were characterised by mid-range levels of GATA6
and heterogeneous expression of both EPI and PrE markers
(Fig. 4B). We infer that these intermediates may represent ICM
cells in the process of transition to either lineage. Nonetheless, a
substantial number of ICM cells have advanced to mature EPI and
PrE identities and readily resolve into distinct populations, a finding
that becomes apparent when our selection process is applied
(Fig. S4C,D). Thus, subpopulations of EPI and PrE cells have
acquired distinct fates by the late blastocyst stage whereas other
ICM cells appear to be transitory.
We identified additional lineage-associated genes consistently
expressed in the corresponding cell types (Fig. S4E,F). The primate-
specific PrE marker RSPO3 (Boroviak et al., 2015) was upregulated
in re-classified PrE cells, whereas EPI cells featured the
pluripotency markers PRDM14, TFCP2L1 and ZFP42. Mouse-
specific factors of the pluripotency network, including KLF2,
NR0B1 and FBXO15 (Blakeley et al., 2015; Boroviak et al., 2015)
were absent. Differentially expressed genes were then identified
between EPI and PrE (Fig. 4C, Table S2). Consistent with previous
observations, we found primate-specific EPI expression of ARGFX,
NODAL and LEFTY2, whereas components of BMP signalling were
evident in PrE cells (Blakeley et al., 2015; Boroviak et al., 2015;
Petropoulos et al., 2016). Gene ontology (GO) analysis of transcripts
modulated between EPI and PrE populations showed enrichment for
apoptosis, cell proliferation and embryo development in EPI cells.
PrE-related processes included cell migration, metabolism and
vascular development (Fig. 4D). Finally, we assessed the purity of
EPI and PrE samples with t-SNE based on lineage markers. We
obtained tight separation between the two groups (Fig. 4E), indicating
that they comprise distinct and representative populations of mature
EPI and PrE cells.
Pseudotime staging and non-human primate-derived marker
expression define the early ICM
Cells from early blastocyst (E5) embryos were profiled only in the
Petropoulos study. PCA suggested the presence of a heterogeneous
mixture of cells (Fig. 5A). Combining developmental pseudotime
(Fig. 5A)with hierarchical clustering (Fig. S5A) allowed us to resolve
an early cluster comprising 43 of 336 E5 cells (Fig. 5A, early ICM).
In agreement with Petropoulos et al., we could not detect an EPI, PrE
or TE signature in this population (Fig. 5B). Instead, we observed
intermediate levels of both SOX2 andGATA3 (Fig. S5B), indicating a
subset of cells expressing a mixture of ICM and TE lineage markers.
Analysis of genes contributing to the first and second principal
components revealed an early TE population displaying high levels
of GATA2, GATA3 and DAB2 (Fig. S5C). ICM cells expressing
IFITM1,GDF3 and ARGFX formed a separate group, consistent with
the cell types assigned by Petropoulos et al. (Fig. 5B, Fig. S5C).
To date, defined markers of the early human ICM have not been
proposed. In studies of non-human primates, ESRRB has recently
been identified as an early ICM-specific gene in cynomolgus
macaque (Nakamura et al., 2016) and common marmoset (T.B.,
G.G.S., S. Dietmann, I. H. Herraez, H. Mohammed, W. Reik, A.S.,
E. Sasaki, J.N. andP.B., unpublished).ESRRB is robustly expressed in
the putative human early ICM population and is downregulated in
EPI, together with other early ICM-specific genes, ATG2A and
MAGEA4 (Fig. 5C). Inclusion of ‘early E5’ cells from the Petropoulos
study, collected several hours prior to those designated E5 by in vitro
fertilisation (IVF) staging (Fig. S5D), resulted in substantial overlap
with the early ICM population. This result independently confirmed
cell-type assignments inferred by pseudotime analysis.
To further assess whether early ICM, EPI and PrE cells can be
discerned as separate populations, we performed weighted gene
network cluster analysis (WGCNA; Zhang and Horvath, 2005;
Langfelder and Horvath, 2007) based on highly variable genes (Fig.
S5E). Using this approach, we extracted gene modules defined by co-
expression combined with unsupervised clustering. We identified 14
initial modules, which could be reduced to seven based on similarity
metrics (Fig. S5F). Importantly, eigengene clusters based on Pearson
correlation independently captured our previously refined cell
populations. We used the 50 most highly connected genes to define
co-expression networks for PrE (Fig. 5E), ICM (Fig. 5F) and EPI
(Fig. 5G) lineages (Table S3). PDGFRA, BMP6, RSPO3, COL4A1
and GATA4 were the major hub genes for the PrE network, whereas
GDF3, together with NANOG, IFITM1, IFITM3, TDGF1 were
highly co-expressed in the EPImodule. Predominant hub genes in the
early ICM network consisted of MFN1, CYP26A1, NANOGNB,
PRAMEF17 and PRAMEF20. These results demonstrate that early
ICM, EPI and PrE can be resolved as distinct transcriptional states.
A unified transcription map of human pre-implantation
development
We then integrated samples from earlier developmental stages
spanning zygote to compacted morula (Yan et al., 2013), analysing
these in tandem with the refined classifications of early ICM, EPI
and PrE established above (Tables S4, S5). PCA produced stage-
specific clusters (Fig. 6A), verifying that the cell populations
established here reflect distinct embryonic lineages. We then
generated self-organising feature maps (Kohonen, 1982) from this
combined dataset to extract the most prominent stage-specific
transcription factors, chromatin modifiers and biological processes
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operative in human pre-implantation development (Fig. 6B,
Table S6). Genes were ranked by expression level and Z-score,
which in turn captured specific embryo stages as an emergent
property. Embryonic genome activation at the 8-cell stage was
characterised by RNA metabolic processes and expression of
LEUTX, a homeobox gene recently associated with this event and
without an orthologue in mouse (Maeso et al., 2016). Expression of
KLF17 also peaked at the 8-cell stage. We found ZNF296, encoding
a pluripotency-associated protein reported to interact with the
reprogramming factor Klf4 in mouse (Fischedick et al., 2012; Fujii
et al., 2013; Matsuura et al., 2017), to be specifically expressed in
compacted morulae. Five of the top ten genes upregulated at the late
ICM stage are mutually exclusive to EPI (LEFTY2, IFITM1 and
LEFTY2) or PrE (APOA1 and RSPO3) lineages.
We sought to identify progressive drivers of EPI and PrE
specification in human (Fig. 6C-F). The transcriptional regulators
ARGFX, PRDM14, SOX2, NANOG and DPPA2 were expressed
from the point of embryonic genome activation and maintained in
the EPI, but downregulated in PrE (Fig. 6C, Fig. S6A). Strikingly,
EPI-specific genes, and specifically those upregulated in mature EPI
cells, included several agonists of FGF, activin A/Nodal and WNT
signalling, such as FGF4, GDF3, NODAL, LEFTY2, TDGF1 and
WNT3 (Fig. 6D, Fig. S6B). Notable early PrE-associated genes were
GATA6, LAMA1, HNF4A, DUSP1 and MARCKS (Fig. 6E,
Fig. S6C). In contrast, RSPO3, GATA4, APOA1, SOX17, FOXA2,
APOA2, PDGFRA and BMP2 were upregulated de novo in the
mature PrE (Fig. 6F, Fig. S6D). This molecular classification of
early and late EPI and PrE lineages (Table S7) is thus a means to
stage human pre-implantation development and provides a basis for
functional interrogation.
Characteristics of human pluripotent stem cell lines
Pluripotent stem cells (PSCs) can be derived from explant cultures
of human blastocyst ICM (Thomson et al., 1998; O’Leary et al.,
2012) and propagated ex vivo in the presence of FGF and activin or
TGFβ (James et al., 2005; Vallier et al., 2005; Xu et al., 2005).
Having established a defined sequence of early human embryo
progression, we sought to relate the transcriptional status of PSCs
cultured in vitro to embryonic lineages. We compiled an extensive
dataset of human PSC lines cultivated in standard conditions (see
Materials and Methods), several modalities that support the
transition from conventional PSC to a naïve state with
transcriptomic, epigenetic and metabolic features similar to
canonical mouse embryonic stem cells (Takashima et al., 2014;
Theunissen et al., 2014; Guo et al., 2016, 2017), alternative methods
where the presumption of a naïve identity has been advanced but not
corroborated (Gafni et al., 2013; Ware et al., 2014), and a recent
report describing cells proposed to possess extended developmental
potential (Yang et al., 2017).
PCA (Fig. 7A), hierarchical clustering (Fig. S7A) and t-SNE
(Fig. S7B) consistently partitioned samples into two broad groups,
unambiguously distinguishing naïve from conventional and
alternative cultures. The naïve cluster exclusively comprised cells
reported in four studies: conversion of conventional human PSCs to
a naïve state using 5i/L/A (MEKi, GSK3βi, BRAFi, SRCi, ROCKi,
LIF, activin A) (Theunissen et al., 2014) and three studies
employing t2iLGö (MEKi, GSK3i, LIF, PKCi) in transgene-
mediated resetting (Takashima et al., 2014), derivation of de novo
cell lines directly from dissociated ICM cells (Guo et al., 2016), and
chemical resetting (cR) (Guo et al., 2017). Included in the last
dataset were cells cultivated in feeder-free conditions on a laminin
attachment substrate. These clustered with other samples in the
naïve group (Fig. 7A, Fig. S7B).
PSC lines maintained in modified NHSM/4i and serum
replacement factors (MEKi, GSK3i, LIF, FGF2, TGFβ1, p38i,
JNKi, ROCKi, KSR) (Irie et al., 2015; Sperber et al., 2015), or
generated by transient exposure to histone deacetylase inhibitors
followed by propagation in alternative media (MEKi, GSK3i, LIF,
FGF2, IGF1, ROCKi, KSR) (Sperber et al., 2015) were interspersed
with those cultured in conventional conditions by global
dimensionality reduction methods (Fig. 7A, Fig. S7A,B). These
results are consistent with previous studies in which the relationship
of these cells to standard PSCs was assessed (Huang et al., 2014;
Nakamura et al., 2016; Pastor et al., 2016). Statistical testing
identified ‘Preimplantation Embryo’ as the topmost ranked
functional pathway based on genes enriched in the naïve sample
cluster, whereas ‘Ectoderm Differentiation’ was most associated
with conventional PSCs. This is in agreement with reports
suggesting that naïve stem cells represent an early stage of
embryonic development (Huang et al., 2014; Theunissen et al.,
2016) whereas conventional primate PSCs more closely resemble
the post-implantation epiblast (Nakamura et al., 2016).
Using the composite single-cell embryo dataset as a reference, we
then explored the relationship between human PSC cultures and
embryonic lineages over developmental time. Initial clustering by
PCA indicated sample processing methods to be the main
contributor to PC1, likely arising from technical factors inherent
to single-cell and bulk RNA-seq protocols (Fig. 7B). PC2 resolved
developmental timing, and aligned in vitro cultured PSCs with ICM
stages. This result was recapitulated by alternative global
dimensionality reduction methods (Fig. S7C). To increase the
resolution of cluster separation, we re-plotted PSC datasets with
compacted morula, early ICM and late ICM embryo samples
(Fig. S7D). PSCs were invariably observed in closest proximity to
late ICM. Confining the analysis to late ICM and in vitro samples
alone resolved distinct groups of EPI and PrE embryo cells, and
separated naïve and conventional PSC cultures (Fig. 7C). Notably,
naïve PSCs aligned with EPI cells along the third dimension.
As an alternative approach, we employed quadratic
programming to compare cell expression profiles between PSCs
and embryonic tissues based on the entire transcriptome (Gong
and Szustakowski, 2013). This allowed us to compute fractional
identity between PSC cultures and pre-implantation embryo
lineages (Fig. 7D). Naïve PSCs showed the greatest shared
identity with EPI cells, over 0.75 for laminin cultures, in contrast
to conventional PSCs and other alternatives, which consistently
displayed lower correspondence (<0.54). We also performed
correlation analysis based on genes dynamically expressed over
developmental time (Fig. S7E). We observed a gradual increase in
correlation with embryonic progression, most prominently with
the EPI subset.
Fig. 4. Selection and characterisation of EPI and PrE cells. (A) Cluster
dendrogram of POU5F1-high and POU5F1-medium late ICM cells, selected
based on the first and second principal components from the analysis shown
in Fig. 3F. Sample colours are scaled to the ratio of NANOG to PDGFRA
expression. (B) Single-cell dot plots showing log2 FPKM values of the genes
indicated. Cells are ordered along the x-axis to correspond to the dendrogram
in A. (C) Two-way clustering of the top 20 genes up- and downregulated
between EPI and PrE samples. (D) Network of biological processes enriched
for genes modulated between EPI and PrE. Nodes represent processes; edge
weight reflects the degree of intersection between gene lists. Node size is
proportional to the number of contributing genes and colours reflect the ratio
between those up- and downregulated. (E) t-SNE plot for EPI and PrE cells.
Sample colours are scaled to the ratio of NANOG to PDGFRA expression.
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Finally, we compared in vitro cultured cells with the embryo
based on genes differentially expressed between naïve and
conventional PSC sample clusters (Table S9). The two groups
were clearly separated; naïve samples most closely resembled EPI
cells (Fig. 7E; 0.66-0.8 for naïve versus 0.19-0.44 for conventional
PSCs). Interestingly, reset cells (Takashima et al., 2014) were also
correlated to varying degrees with PrE (0.61-0.73), early ICM
(0.54-0.67) and compacted morulae (0.5-0.64). Cells adapted to 5i/
L/A (Ji et al., 2016) exhibited the highest correlation (0.8) with both
EPI and PrE. Cultures of embryo-derived (Guo et al., 2016) and
chemically reset (Guo et al., 2017) cells in t2iLGö were correlated
with EPI and 5i/L/A cells to a similar extent, but to a lesser extent
with PrE. These findings indicate that human PSCs maintained in
t2iLGö represent cogent transcriptional counterparts to the naïve
epiblast lineage of the human pre-implantation embryo and suggest
that 5i/L/A cells represent a mixed EPI/PrE identity.
DISCUSSION
Here, we present an analysis and classification of single-cell gene
expression data from human embryos, and define accurate
transcriptional prototypes of EPI and PrE lineages emergent in the
late blastocyst. We integrated data from disparate profiling studies
and determined representative cell populations that distinguish
nascent and differentiating tissues. The resulting dataset is
consistently partitioned by developmental stage and cell type
using multiple dimensionality reduction methods, and the
constituent cell populations faithfully recapitulate expression and
localisation patterns of established embryonic lineage markers.
WGCNA independently clustered samples into groups consisting
of early ICM, EPI and PrE. This partitioning allows further
exploration of specific gene sets, including those encoding
extracellular matrix proteins and signalling pathway components,
transcriptionally active during progression from unspecified ICM to
mature EPI and PrE lineages. EPI cells lack expression of several
genes active in mouse EPI and embryonic stem cells (ESCs), such as
ESRRB, FBXO15, NR0B1 and KLF2, consistent with previous
reports in human (Blakeley et al., 2015; Petropoulos et al., 2016)
and non-human primates (Boroviak et al., 2015; Nakamura et al.,
2016). The human naïve pluripotency network includes the
transcription factors MYBL2, ARGFX, SOX4, PRDM14, KLF4,
TFCP2L1, GDF3 and KLF17. We identify markers of early lineage
EPI and PrE specification, many of which are expressed from
embryonic genome activation at the 8-cell stage, such asKLF17 and
ARGFX. The temporal sequence of human PrE transcription factor
acquisition was surprisingly well-conserved relative to the rodent
paradigm (Plusa et al., 2008; Rossant and Tam, 2009; Artus et al.,
2011; Schrode et al., 2014). GATA6 preceded SOX17, followed by
GATA4 and FOXA2 in the ICM; however, we did not detect PrE-
specific expression of SOX7.
Immunofluorescence studies of the human blastocyst have shown
that EPI and PrE segregation is manifest prior to implantation,
between E6 and E7 (Roode et al., 2012; Niakan and Eggan, 2013;
Deglincerti et al., 2016). Similar observations have been made in
non-human primates. The early marmoset ICM co-expresses
GATA6 and NANOG, before the point at which EPI and PrE
lineages diverge (Boroviak et al., 2015). In cynomolgus monkey,
the early ICM comprises a distinct population that subsequently
undergoes EPI and PrE segregation at the late blastocyst stage,
similar to mouse (Nakamura et al., 2016; Ohnishi et al., 2014).
Consistent with these findings, our analyses support a discrete
developmental state embodied by the early human ICM, different in
composition from mature EPI or PrE.
Petropoulos et al. instead proposed concurrent establishment of
EPI, PrE and TE lineages during blastocyst formation at E5. An
overlap between acquisition of ICM versus TE identity and EPI and
PrE specification is not excluded by our analysis, but, in that event,
divergence of EPI and PrE would commence in a subset of ICM
cells at E5 and progress incrementally through E6. Segregation of
EPI and PrE appears to continue for at least one cell division cycle in
mouse (Saiz et al., 2016). Consistent with the hypothesis of
Petropoulos et al., we identified a fraction of E5 cells that express
lineage-specific markers. However, it is conversely plausible that
these cells were obtained from more advanced embryos. Staging of
human embryos is not as precise as the rodent model, and it could be
that some human IVF-derived blastocysts are more or less
developmentally mature than embryonic day would imply.
The revised lineage assignments presented here clearly demarcate
late ICM populations into EPI, PrE and putative transitional
intermediates observed between EPI and PrE in the late blastocyst.
The fate of these intermediates remains an open question. Pathway
analysis of prototypical EPI cells revealed significant enrichment
for apoptosis, which could facilitate selective elimination of
unspecified cells. Alternatively, these cells might persist for some
time before commitment to a particular lineage.
Human and non-human primate PSCs propagated in vitro by
conventional culture methods differ substantially from pluripotent
cells resident in the pre-implantation embryo with respect to
transcriptome (Yan et al., 2013; Nakamura et al., 2016) and
methylome (Guo et al., 2014). Conventional self-renewing PSC
lines share distinguishing features with stem cells derived from
mouse post-implantation epiblast (Brons et al., 2007; Tesar et al.,
2007), which has led to the proposition that these cultures have
progressed in vitro towards a later stage of development (Nichols
and Smith, 2009; Davidson et al., 2015). A genuine primate
analogue to rodent ESCs has been sought in recent years. That goal
has remained elusive, and it has been unclear whether suboptimal
culture conditions and/or species differences in pluripotency
networks impeded the capture of human naïve cells with
properties similar to authentic ESCs.
The degree to which various in vitro methods promote the
conversion of human PSCs to a naïve state has been assessed in
terms of global transcription, induction or suppression of
pluripotency-associated and lineage marker genes, activation of
retroviral element families, genome-wide DNA methylation, X
chromosome activation, and other properties (Huang et al., 2014;
Pastor et al., 2016; Nakamura et al., 2016; Theunissen et al., 2016;
Liu et al., 2017). The sequence of human pre-implantation
development that we have derived allows comprehensive
transcriptome comparison of embryo stages with PSCs
propagated in various culture systems. In agreement with earlier
reports, we found that independent samples of PSCs maintained in
NSHM/4i (Irie et al., 2015; Sperber et al., 2015) did not appreciably
diverge from conventional cultures in transcriptional state.
Extended pluripotent stem (EPS) cells (Yang et al., 2017) were
correlated with conventional PSCs on a global level and not with
any pre-implantation embryo stage, suggesting that any altered
Fig. 6. WGCNA and global analysis of human pre-implantation
development. (A) PCA of zygote, 4-cell, 8-cell and compacted morula
samples from the Yan dataset combined with our selection of early ICM cells
from Petropoulos et al. and the refined subset of EPI and PrE from all three
studies. (B) Self-organising maps of selected transcription factors, chromatin
modifiers and significant biological processes across developmental stages.
(C-F) Expression in FPKM of selected markers for early EPI (C), late EPI (D),
early PrE (E) and late PrE (F).
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potential might be an in vitro adaptation conferred by a relatively
small-scale regulatory perturbation.
In contrast to the above, cells converted to a naïve state by
exogenous transgene expression or chemical resetting and
propagated in t2iLGö (Takashima et al., 2014; Guo et al., 2017),
de novo embryo-derived naïve PSC lines established in similar
conditions (Guo et al., 2016), and PSCs maintained in 5i/L/A
(Theunissen et al., 2014) retained strong correspondence to cells of
the pre-implantation embryo. These naïve pluripotent cultures were
also variably correlated with PrE, early ICM and compacted morula.
Mouse PrE and EPI display global transcriptional similarity despite
differential expression of lineage specifiers (Boroviak et al., 2015).
The apparent concordance between naïve PSCs and PrE is probably
rooted in the intrinsic global similarity between EPI and PrE.
However, the strongest degree of similarity was observed
between naïve cultures and EPI. The correspondence was closest
for 5i/L/A cultures, and for feeder-free human naïve embryonic
stem (HNES) cells and chemically reset PSCs in t2iLGö.
We therefore conclude that these culture regimes capture self-
renewing pluripotent cell populations characterised by
transcriptomes that approximate to the in vivo pre-implantation
epiblast.
MATERIALS AND METHODS
RNA-seq data processing
Sequencing data were obtained from the European Nucleotide Archive
(Toribio et al., 2017) from single-cell human embryo profiling studies
[accession numbers: SRP011546 (Yan et al., 2013), SRP055810 (Blakeley
et al., 2015), ERP012552 (Petropoulos et al., 2016)]; H1 (SRP014320;
Djebali et al., 2012) and H9 (ERP007180; Wellcome Trust Sanger Institute)
PSC lines cultured in standard conditions; H9 cells in conventional
conditions and reset to naïve pluripotency (ERP006823; Takashima et al.,
2014); conventional and chemically reset Shef6 cultures (ERP022538; Guo
et al., 2017); epiblast-derived HNES cells (ERP014247; Guo et al., 2016)
and independent cultures of the HNES1 clonal line (ERP022538; Guo et al.,
2017); WIBR lines converted to a naïve state in 5i/L/A (SRP059227;
Ji et al., 2016); WIS cells cultured in NSHM/4i (SRP045294; Irie et al.,
2015); H1 and Lis1 lines independently cultured in NHSM/4i (SRP045911;
Sperber et al., 2015); conventional H1 and Elf1 cells (SRP045911;
Sperber et al., 2015); and EPS cells reported to contribute to extra-
embryonic tissues (SRP074076; Yang et al., 2017). Reads were aligned to
human genome build GRCh38/hg38 with STAR 2.5.2b (Dobin et al.,
2013) using the two-pass method for novel splice detection (Engström
et al., 2013). Read alignment was guided by GENCODE v25 (Harrow
et al., 2012) human gene annotation from Ensembl release 87 (Yates et al.,
2016) and splice junction donor/acceptor overlap settings were tailored to
the read length of each dataset. Alignments to gene loci were quantified
with htseq-count (Anders et al., 2015) based on annotation from Ensembl
87. Sequencing libraries with fewer than 500,000 mapped reads were
excluded from subsequent analyses. Read distribution bias across gene
bodies was computed as the ratio between the total reads spanning the 50th
to the 100th percentile of gene length, and those between the first and 49th.
Samples with ratio >2 were not considered further. Stage-specific outliers
were screened by PCA.
Transcriptome analysis
Principal component and cluster analyses were performed based on log2
FPKM values computed with the Bioconductor packages DESeq2 (Love
et al., 2014), Sincell (Juliá et al., 2015) or FactoMineR (Lê et al., 2008) in
addition to custom scripts. t-SNE (van der Maaten and Hinton, 2008) and
diffusion maps were produced with the Rtsne (github.com/jkrijthe/Rtsne) and
destiny (Angerer et al., 2016) packages, respectively. Differential expression
analysis was performed with scde (Kharchenko et al., 2014), which fits
individual error models for the assessment of differential expression between
sample groups. For global analyses, genes that registered zero counts in all
single-cell samples in a given comparison were omitted. Euclidean distance
and average agglomeration methods were used for cluster analyses. Fractional
identity between pre-implantation stages and in vitro cultured cells was
determined via quadratic programming using the R package DeconRNASeq
(Gong and Szustakowski, 2013). Average expression levels of cells
comprising distinct stages were used as the ‘signature’ dataset, and the
relative identity of each culture protocol/sample group was computed by
quadratic programming. Expression data are available in Table S8 and
through a web application to visualise transcription of individual genes in
embryonic lineages (app.stemcells.cam.ac.uk/human-embryo).
Selection of high-variability genes
Genes exhibiting the greatest expression variability (and thus contributing
substantial discriminatory power) were identified by fitting a non-linear
regression curve between average log2 fragments per kilobase of transcript
per million mapped reads (FPKM) and the square of coefficient of variation.
Thresholds were applied along the x-axis (average log2 FPKM) and y-axis
(log CV2) to identify the most variable genes. Depending on the samples
compared, selection results were affected mostly by technical factors
(library construction protocol, RNA-seq coverage, read distribution) where
such properties differed between studies and datasets. To reduce these
effects, when data frommultiple studies were treated in a single analysis, we
first identified variable genes independently for each dataset and then
selected those genes common to each.
Network analysis of biological processes
Statistical enrichment of GO terms was computed withGOstats and DAVID
6.8 (Huang et al., 2009), using modulated genes as input (e.g. between EPI
and PrE cells, adjusted P<0.05). Cytoscape (Shannon et al., 2003) and the
associated enrichment map plugin (Isserlin et al., 2014) were used for
network construction and visualisation. For network diagrams, node size is
scaled by the number of genes contributing to over-representation of
biological processes; edges are plotted in width proportional to the overlap
between gene sets. The ratio between up- and downregulated genes between
cell populations (e.g. EPI and PrE) in each biological process is represented
by colour shade (e.g. red, more genes upregulated in EPI; blue, more genes
upregulated in PrE; see Fig. 4D).
Evaluation of refined embryonic cell populations
To assess the accuracy of selected EPI, PrE and early ICM cells, we used the
weighted gene correlation network analysis (WGCNA) unsupervised
clustering method (Langfelder and Horvath, 2008) to identify specific
modules of co-expressed genes in each developmental lineage. A soft power
threshold of 10 was set to govern the correlation metric and a tree pruning
approach (Langfelder et al., 2008) was implemented to merge similar
modules (threshold 0.35). The minimum module size was set to 50 genes;
from the modules computed, the top 50 genes with greatest intramodular
connectivity were selected for subsequent co-expression network analysis.
Identification of early and late pre-implantation lineage markers
The R package kohonenwas used to construct self-organising transcriptome
maps across embryonic stages. A matrix of 30×30 with hexagonal topology
was used to map and identify areas of varying transcriptional activity.
The GOstats package was used for stage-specific GO analyses considering
genes with Z-score >1.5. Genes with Z-score <1.5 in all stages were used for
the background set (universe). Annotation related to transcription factors,
co-factors and chromatin remodellers was obtained from AnimalTFDB 2.0
(Zhang et al., 2015). Late lineage markers were selected as genes expressed
Fig. 7. Comparison of human pluripotent cell lines with embryonic
stages. (A) PCA based on highly variable genes (n=1760, log2 FPKM>2, log
CV2>0.5). (B) PCA based on global gene expression for all pre-implantation
stages and PSC cultures. (C) PCA of late blastocyst stages (red, EPI; blue,
PrE) and PSC cultures. (D) Fraction of identity of PSC cultures to EPI cells.
Similarity between cultured PSCs and all pre-implantation embryo stages was
computed by quadratic programming; plotted is the fraction identity of PSCs to
EPI, with samples sorted accordingly. (E) Clustering of Pearson correlation of
genes differentially expressed between naïve and conventional PSCs to
embryo stages and lineages (n=2860, adjusted P<0.001, absolute log2 fold
change>1.5).
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in EPI or PrE cells with a transcriptional contribution >75% across all
selected pre-implantation stages and minimum level of 10 FPKM. Early
markers were identified as genes in later stages (from 8-cell morulae to
either EPI or PrE lineages) with a transcriptional contribution of >75%
across all selected pre-implantation stages. A fold change induction of at
least four between lineages andminimum level of 10 FPKM in at least in one
of the following stages was required: 8-cell, compacted morula, early ICM,
EPI or PrE.
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